HighTower Advisors
TEVA icon

HighTower Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

HighTower Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Sell
205,600
-18,467
-8% -$615K 0.01% 1080
2026
Q1 		$6.75M Buy
224,067
+43,243
+24% +$1.39M 0.01% 1054
2025
Q4 		$5.64M Buy
180,824
+8,022
+5% +$198K 0.01% 1108
2025
Q3 		$3.49M Buy
172,802
+108,311
+168% +$1.9M ﹤0.01% 1315
2025
Q2 		$1.08M Sell
64,491
-119,044
-65% -$1.92M ﹤0.01% 1959
2025
Q1 		$2.82M Sell
183,535
-13,122
-7% -$234K ﹤0.01% 1338
2024
Q4 		$4.33M Buy
196,657
+48,052
+32% +$874K 0.01% 1108
2024
Q3 		$2.67M Buy
148,605
+122,154
+462% +$2.14M ﹤0.01% 1336
2024
Q2 		$430K Sell
26,451
-903
-3% -$13.9K ﹤0.01% 2427
2024
Q1 		$383K Buy
27,354
+108
+0.4% +$1.36K ﹤0.01% 2487
2023
Q4 		$283K Sell
27,246
-5,344
-16% -$49.9K ﹤0.01% 2751
2023
Q3 		$331K Buy
32,590
+425
+1% +$3.96K ﹤0.01% 2519
2023
Q2 		$245K Sell
32,165
-150,834
-82% -$1.22M ﹤0.01% 2711
2023
Q1 		$1.61M Sell
182,999
-110,414
-38% -$1.09M ﹤0.01% 1416
2022
Q4 		$2.69M Sell
293,413
-17,601
-6% -$154K 0.01% 1119
2022
Q3 		$2.5M Sell
311,014
-75,117
-19% -$664K 0.01% 1102
2022
Q2 		$2.9M Buy
386,131
+57,667
+18% +$502K 0.01% 1055
2022
Q1 		$3.08M Buy
328,464
+99,737
+44% +$832K 0.01% 1126
2021
Q4 		$1.83M Sell
228,727
-27,550
-11% -$249K ﹤0.01% 1410
2021
Q3 		$2.5M Buy
256,277
+200,640
+361% +$1.88M 0.01% 1141
2021
Q2 		$554K Buy
55,637
+1,424
+3% +$15.1K ﹤0.01% 1994
2021
Q1 		$631K Buy
54,213
+6,036
+13% +$69.2K ﹤0.01% 1835
2020
Q4 		$466K Buy
48,177
+13,162
+38% +$126K ﹤0.01% 1673
2020
Q3 		$318K Sell
35,015
-170
-0.5% -$1.8K ﹤0.01% 1802
2020
Q2 		$431K Buy
35,185
+650
+2% +$7.35K ﹤0.01% 1538
2020
Q1 		$307K Buy
34,535
+3,770
+12% +$38.6K ﹤0.01% 1559
2019
Q4 		$302K Sell
30,765
-8,188
-21% -$73.1K ﹤0.01% 1718
2019
Q3 		$261K Sell
38,953
-21,980
-36% -$168K ﹤0.01% 1894
2019
Q2 		$564K Buy
60,933
+20,042
+49% +$242K ﹤0.01% 1461
2019
Q1 		$648K Sell
40,891
-2,203
-5% -$38.8K ﹤0.01% 1323
2018
Q4 		$665K Sell
43,094
-16,966
-28% -$348K 0.01% 1214
2018
Q3 		$1.29M Sell
60,060
-74,253
-55% -$1.72M 0.01% 1020
2018
Q2 		$3.25M Buy
134,313
+82,092
+157% +$1.67M 0.03% 649
2018
Q1 		$890K Sell
52,221
-5,150
-9% -$101K 0.01% 1134
2017
Q4 		$1.08M Sell
57,371
-26,336
-31% -$396K 0.01% 1065
2017
Q3 		$1.48M Sell
83,707
-251,229
-75% -$5.65M 0.01% 932
2017
Q2 		$11.1M Sell
334,936
-324
-0.1% -$10K 0.1% 219
2017
Q1 		$10.8M Buy
335,260
+156,372
+87% +$5.34M 0.1% 199
2016
Q4 		$6.49M Buy
178,888
+89,770
+101% +$3.58M 0.07% 297
2016
Q3 		$4.11M Sell
89,118
-985
-1% -$51.4K 0.05% 421
2016
Q2 		$4.58M Sell
90,103
-20,248
-18% -$1.08M 0.06% 356
2016
Q1 		$5.91M Sell
110,351
-58,209
-35% -$3.42M 0.02% 335
2015
Q4 		$11.1M Sell
168,560
-8,479
-5% -$524K 0.13% 172
2015
Q3 		$10M Buy
177,039
+14,231
+9% +$923K 0.13% 170
2015
Q2 		$9.62M Sell
162,808
-78,097
-32% -$4.82M 0.15% 134
2015
Q1 		$12.2M Buy
240,905
+61,063
+34% +$3.55M 0.18% 125
2014
Q4 		$10.3M Buy
179,842
+16,847
+10% +$939K 0.16% 144
2014
Q3 		$8.76M Sell
162,995
-44,935
-22% -$2.38M 0.15% 155
2014
Q2 		$10.9M Buy
207,930
+5,501
+3% +$281K 0.19% 119
2014
Q1 		$10.7M Buy
202,429
+100,238
+98% +$4.63M 0.21% 107
2013
Q4 		$4.1M Sell
102,191
-36,835
-26% -$1.45M 0.08% 266
2013
Q3 		$5.25M Sell
139,026
-1,720
-1% -$67.1K 0.13% 185
2013
Q2 		$5.52M Buy
+140,746
New +$5.48M 0.15% 159

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

HighTower Advisors's TEVA Position: Q2 2026 in Review

HighTower Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 8.2% in Q2 2026, selling an estimated $615K and leaving 205,600 shares worth $6.97M. The position accounts for 0.01% of the portfolio, ranked #1080.

HighTower Advisors first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.2M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • HighTower Advisors held 205,600 shares of Teva Pharmaceuticals worth $6.97M as of Q2 2026.
  • HighTower Advisors sold 18,467 Teva Pharmaceuticals shares in Q2 2026, an estimated $615K.
  • Teva Pharmaceuticals made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1080 holding.
  • HighTower Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Teva Pharmaceuticals position peaked at $12.2M in Q1 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.